Clinical Trial Search

Primary: Histologic Thermal Injury to Epigastric Port Site Skin — 1; 7 participants

Primary: Symptoms of Depression in Congestive Heart Failure Patients With Clinical Depression After Treatment With Sertraline or Placebo — -7.1; -6.8 HDRS Change Score — p=0.89

Primary: Change in Total International Prostate Symptom Score (IPSS) From Baseline to 12 Weeks — -5.18; -3.76 units on a scale — p=0.001

Primary: Wound Are at Baseline

Primary: Progression-free Survival at 2 Years — 76; 80 percentage of participants — p=0.11

Primary: Summary of Antibody Persistence at 18 Months of Age in Participants That Received Primary Series Vaccination of Either DTaP-IPV-HepB-PRP~T or PENTAXIM™ and ENGERIX B®…

Primary: Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) — -40.1 Percent Change

Primary: Change From Single-Blind Baseline in Mean Pain Score at Week 19 During Double-Blind Phase — 6.8; 6.7; -3.9; -3.5 units on a scale — p=0.1221

Primary: Percentage of Participants Reporting Pre-Specified Local Reactions — 32.1; 30.0; 30.4; 36.7 Percentage of Participants

Primary: Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series — 94.4; 98.0; 87.3; 92.8…

Primary: Percentages Of Subjects Who Achieved HI Titer ≥40 After One Vaccination of Cell Culture-derived (cTIV) or Egg-derived (TIV) Influenza Subunit Vaccines — 29; 33; 30; 31…

Primary: Acrophobia Questionnaire With Avoidance (AAVQ) — 9.00; 12.38 units on a scale

Primary: Number of Participants With Adverse Events (AEs) — 184; 334 participants

Primary: Rate of Change in Composite Manual Muscle Testing (MMT) Score — 0.44; 0.39 MMT units per month — p=0.529

Primary: Average Pain Severity Score — 62 mm